2005
DOI: 10.1002/jlcr.922
|View full text |Cite
|
Sign up to set email alerts
|

Manufacturing I-123-labelled radiopharmaceuticals. Pitfalls and solutions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
28
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 44 publications
(28 citation statements)
references
References 29 publications
0
28
0
Order By: Relevance
“…in MeCN/TFA (7:3), and under these conditions, the conversion of 5, 6, and 7 into the iodo products was 1, 5, and 20 %, respectively. In complete absence of Tl(OCOCF 3 ) 3 , no conversion of the starting material took place, and this underlines that protodesilylation does not occur under the conditions.…”
Section: Resultsmentioning
confidence: 81%
See 4 more Smart Citations
“…in MeCN/TFA (7:3), and under these conditions, the conversion of 5, 6, and 7 into the iodo products was 1, 5, and 20 %, respectively. In complete absence of Tl(OCOCF 3 ) 3 , no conversion of the starting material took place, and this underlines that protodesilylation does not occur under the conditions.…”
Section: Resultsmentioning
confidence: 81%
“…In continuation of the work by McKillop et al, a regioselective variant of the iodination method was published by Bell et al [18] They discovered that trimethylsilyl (TMS)-substituted aryls, such as 3-trimethylsilyltoluene, undergo ipso substitution when treated with Tl(OCOCF 3 ) 3 , whereas none of the other regioisomers are formed above trace levels. Furthermore, the introduction of the TMS group increases the reactivity of the aromatic system, whereby less activated aryls can be thallated and iodinated.…”
Section: Resultsmentioning
confidence: 98%
See 3 more Smart Citations